Hemophilia B

A recently released statement from the FDA addresses public concerns regarding the approval of several new treatment options for chronic hepatitis C.

An FDA advisory committee has voted to recommend approval of a new drug for the treatment of hypoactive sexual desire disorder in premenopausal women.

The FDA has approved 2 new drugs for the treatment of irritable bowel syndrome and a new option for chronic obstructive pulmonary disease.

...

<p>The U.S Food and Drug Administration said it is asking drugmakers for data on antimicrobials sold for use in each food animal, such as cows and chickens, as part of efforts to combat...

Since its inception in 2009, the FDA’s Safe Use Initiative has collaborated with these stakeholders to investigate new threats to patient safety and develop innovative programs to combat them.

The FDA has issued a warning based on 20 reported cases of ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors for type 2 diabetes.

The FDA has issued a warning based on 20 reported cases of ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors for type 2 diabetes.

The FDA has issued a warning based on 20 reported cases of ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors for type 2 diabetes.

The FDA has granted orphan drug designation to Humira for the treatment of moderate to severe hidradenitis suppurativa (HS; Hurley stage II and III).